Living With Gout in New Zealand

Martini, Nataly; Bryant, Linda; Karu, Leanne Te; Aho, Lenati; Chan, RV Paul; Miao, Jinhua; Naidoo, Caylee; Singh, Harjinder; Tieu, Amanda

doi:10.1097/rhu.0b013e31824e1f6f

Cited by 33 publications

(27 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This has clear implications for the quality and safety of medicines use. In line with earlier work, [ 19 , 20 ] this study revealed lack of knowledge related to the appropriate NSAID dosing for an acute gout flare and confusion around NSAID generic and brand names. Some patients also lacked a clear understanding of the specific and unusual issues around the initiation of allopurinol therapy; an area which has been previously identified as a source of patient confusion [ 19 , 20 , 28 ].…”

Section: Discussionsupporting

confidence: 83%

“…To be considered for preventive treatment patients will have been previously symptomatic, although the level of pain experienced by an individual may vary widely. It is therefore not surprising that here, and in previous studies, [ 19 , 23 ] patients have admitted to failing to take medicines both unintentionally (they were unaware of how it should be taken or simply forgot) and intentionally (they had no desire to take a medicine every day) [ 19 , 23 ]. It is notable that one patient continued to take a medicine to treat gout despite the fact that it exacerbated a co-morbid condition, identifying that patient values and judgments around medicine side-effects may differ from their practitioner’s.…”

Section: Discussionmentioning

confidence: 63%

“…Differing patient and physician perceptions of gout have been identified as one of the challenges to management in primary care [ 16 ]. Issues identified include patients experiencing difficulty in obtaining information they perceive as directly relevant to them, [ 17 ] self-diagnosis and treatment by patients, [ 18 ] a lack of patient knowledge about gout medicines, [ 19 – 22 ] a lack of practitioner knowledge about treatment guidelines and recommendations [ 21 ] and a reluctance on the part of some practitioners to offer preventive medicines as a long-term solution, with some making an assumption that patients would prefer to be treated for an acute flare rather than take long-term medication [ 21 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

et al. 2016

View full text Add to dashboard Cite

BackgroundGout is the most common form of inflammatory arthritis. It is associated with substantial co-morbidity and often managed in primary care. A greater understanding of the communication process between patients and healthcare professionals provides one way of improving the management of this condition. This paper describes communication about gout medicines and treatment between patients and primary care health professionals during routine consultations.MethodsVideo-recordings of 31 individual healthcare consultations between patients and a range of primary care practitioners (general practitioners, practice nurses, podiatrists, dietitians) from an archived database were reviewed. Consultations that encompassed any discussion about gout medicines and treatment were included (n = 27) and were not solely restricted to those where gout was the presenting complaint. Themes were derived from an inductive qualitative analysis, from clinical and linguistic perspectives, based on the conversation between patients and practitioners about medicines and visual observation of these interactions.ResultsA number of factors were identified that had the potential to impact on the optimal management of gout in primary care. These included level of patient knowledge, patient attitudes to medicines, and the attributes of practitioner communication with patients. The latter related to the style of delivery and content of the information provided, and the ability of practitioners to make use of opportunities that arose to discuss these issues.ConclusionsPatients with gout communicate at varying levels of complexity with a diverse range of primary care healthcare professionals about the treatment of their condition. It is important that all practitioners engaging with gout patients in this setting are knowledgeable about the current management of gout, provide clear, consistent and accurate messages, remain aware that these messages may need repeating over time, and are supportive of patients’ medicine-taking preferences.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Discussionmentioning

confidence: 63%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

et al. 2016

View full text Add to dashboard Cite

show abstract

“…However, difficulties can develop where structural foot changes attributable to the arthritis progression make it problematic for patients to find appropriate shoes that are capable of accommodating their foot deformities. Martini et al [ 19 ] reported that people with gout, who experienced symptoms in their lower extremities, were unable to put their shoes on or walk with ease and subsequently stayed at home. To get around the home, they limped, used crutches, or relied on family support to be mobile [ 19 ].…”

Section: Introductionmentioning

confidence: 99%

“…Martini et al [ 19 ] reported that people with gout, who experienced symptoms in their lower extremities, were unable to put their shoes on or walk with ease and subsequently stayed at home. To get around the home, they limped, used crutches, or relied on family support to be mobile [ 19 ]. For people with RA-related foot problems, footwear difficulties can be the source of considerable distress and reinforce negative feelings associated with arthritic foot changes [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

An evaluation of seasonal variations in footwear worn by adults with inflammatory arthritis: a cross‐sectional observational study using a web‐based survey

Brenton‐Rule

Hendry

Barr

et al. 2014

Journal of Foot and Ankle Research

View full text Add to dashboard Cite

Background: Foot problems are common in adults with inflammatory arthritis and therapeutic footwear can be effective in managing arthritic foot problems. Accessing appropriate footwear has been identified as a major barrier, resulting in poor adherence to treatment plans involving footwear. Indeed, previous New Zealand based studies found that many people with rheumatoid arthritis and gout wore inappropriate footwear. However, these studies were conducted in a single teaching hospital during the New Zealand summer therefore the findings may not be representative of footwear styles worn elsewhere in New Zealand, or reflect the potential influence of seasonal climate changes. The aim of the study was to evaluate seasonal variations in footwear habits of people with inflammatory arthritic conditions in New Zealand. Methods: A cross-sectional study design using a web-based survey. The survey questions were designed to elicit demographic and clinical information, features of importance when choosing footwear and seasonal footwear habits, including questions related to the provision of therapeutic footwear/orthoses and footwear experiences.

show abstract

Medication Adherence in Gout: A Systematic Review

Vera

Marcotte

Rai

et al. 2014

Arthritis Care & Research

158

117

View full text Add to dashboard Cite

Objective. Recent data suggesting the growing problem of medication nonadherence in gout have called for the need to synthesize the burden, determinants, and impacts of the problem. Our objective was to conduct a systematic review of the literature examining medication adherence among patients with gout in real-world settings. Methods. We conducted a search of Medline, Embase, International Pharmaceutical Abstracts, PsycINFO, and CINAHL databases and selected studies of gout patients and medication adherence in real-world settings. We extracted information on study design, sample size, length of followup, data source (e.g., prescription records versus electronic monitoring versus self-report), type of nonadherence problem evaluated, adherence measures and reported estimates, and determinants of adherence reported in multivariable analyses. Results. We included 16 studies that we categorized according to methods used to measure adherence, including electronic prescription records (n ‫؍‬ 10), clinical records (n ‫؍‬ 1), electronic monitoring devices (n ‫؍‬ 1), and self-report (n ‫؍‬ 4). The burden of nonadherence was reported in all studies, and among studies based on electronic prescription records, adherence rates were all below 0.80 and the proportion of adherent patients ranged from 10 -46%. Six studies reported on determinants, with older age and having comorbid hypertension consistently shown to be positively associated with better adherence. One study showed the impact of adherence on achieving a serum uric acid target. Conclusion. With less than half of gout patients in real-world settings adherent to their treatment, this systematic review highlights the importance of health care professionals discussing adherence to medications during encounters with patients.

show abstract

Living With Gout in New Zealand

Abstract: There were substantial gaps in the knowledge about gout and its causes and management. All healthcare providers could help identify patients with suboptimal knowledge and improve the management of gout.

Cited by 33 publications

References 18 publications

“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

An evaluation of seasonal variations in footwear worn by adults with inflammatory arthritis: a cross‐sectional observational study using a web‐based survey

Medication Adherence in Gout: A Systematic Review

Contact Info

Product

Resources

About